Trump's Economy Hired Nearly 1 Million Healthcare Workers While Every Other Sector Lost Jobs. Here's Where to Put Your Money

May 2026 nonfarm payrolls reached 159,001 thousand with unemployment steady at 4.3%, while core PCE rose to 129.63 in April and markets now price roughly an 80% probability of zero Fed rate cuts in 2026. The article argues healthcare is the only major sector adding jobs, with 901,000 positions gained since Trump took office, supporting insurers, pharmacy chains, banks, and net-lease REITs in a higher-rate environment. Company updates were constructive for UnitedHealth, CVS, JPMorgan, Humana, and Realty Income, but the broader implication is a prolonged hawkish, higher-for-longer rates backdrop.

Analysis

The market implication is not simply “healthcare wins in a weak labor market”; it is that slow payroll growth plus sticky inflation creates a scarcity premium for businesses with inelastic demand and pricing power. That favors managed care, pharmacy benefit distribution, and certain healthcare services, while leaving cyclicals and rate-sensitive balance sheets trapped in a higher-for-longer discount rate regime. The second-order effect is that the labor share of healthcare profits may improve even if unit growth slows, because labor is being pulled into an administratively heavy sector that can pass through costs more reliably than the rest of the economy.

Rates staying elevated also changes the internal ranking within defensives. Insurers with near-term margin repair and strong cash generation should outperform beneficiaries of volume alone, while REITs only work where management can still underwrite spreads comfortably above Treasury yields. The real risk is not recession in the next few weeks; it is that inflation persistence forces the Fed to remain restrictive into Q4, compressing multiples across dividend proxies even if nominal earnings hold up. That means the trade is less about beta to GDP and more about duration exposure.

The consensus is likely underestimating how much of the current setup is already embedded in healthcare names after the year-to-date run. If the next core inflation print reaccelerates, the market could briefly reward banks and insurers together because both benefit from a steeper-for-longer curve and resilient nominal activity. But if unemployment starts to roll over from here, the same crowded defensives can de-rate quickly as margin relief gets offset by utilization risk and political scrutiny.

Key Decisions for Investors

• Maintain an overweight in UNH/CVS versus the broad market for the next 1-2 quarters; prefer UNH on execution visibility, but trim into strength if the stocks extend much beyond current YTD re-ratings because the easy margin-repair trade is mostly in the price.
• Use HUM as a tactical long only, not a core hold: best risk/reward is post-guidance-reset stabilization, but downside remains high if Star Ratings pressure spills into enrollment or pricing over the next 2 reporting cycles.
• Stay long JPM on a 3-6 month horizon as a higher-for-longer beneficiary; pair against rate-sensitive regional banks or low-growth financials where deposit costs can reprice faster than asset yields.
• For O, favor a call-spread or small long position rather than outright size; the name works if 10-year yields stay range-bound, but it is vulnerable to any move toward possible hikes over the next 1-2 FOMC meetings.
• Hedge dividend/REIT exposure with a small long-duration rate hedge or short IWM vs long XLF/UNH pair: the best risk/reward is owning quality cash-flow compounds and shorting the most rate-sensitive domestic growth exposure.